Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC cut its position in Silicon Laboratories Inc. (NASDAQ:SLAB) by 1.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,193 shares of the semiconductor company’s stock after selling 168 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Silicon Laboratories were worth $1,515,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. FMR LLC boosted its stake in shares of Silicon Laboratories by 1.1% in the third quarter. FMR LLC now owns 4,843,370 shares of the semiconductor company’s stock worth $559,748,000 after acquiring an additional 54,708 shares during the last quarter. Wellington Management Group LLP lifted its position in Silicon Laboratories by 28.3% during the third quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock worth $102,670,000 after buying an additional 195,997 shares in the last quarter. Geode Capital Management LLC lifted its position in Silicon Laboratories by 2.1% during the third quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock worth $90,282,000 after buying an additional 15,728 shares in the last quarter. Clearbridge Investments LLC lifted its position in Silicon Laboratories by 84.0% during the second quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company’s stock worth $30,288,000 after buying an additional 125,022 shares in the last quarter. Finally, Franklin Resources Inc. lifted its position in Silicon Laboratories by 1.9% during the third quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company’s stock worth $27,001,000 after buying an additional 4,278 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. KeyCorp lifted their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research report on Wednesday. JPMorgan Chase & Co. reduced their price objective on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Benchmark reiterated a “hold” rating on shares of Silicon Laboratories in a research report on Tuesday, November 5th. Susquehanna started coverage on Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price objective on the stock. Finally, StockNews.com upgraded Silicon Laboratories to a “sell” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $133.56.

Insider Buying and Selling at Silicon Laboratories

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the completion of the sale, the director now directly owns 32,115 shares of the company’s stock, valued at $4,520,828.55. This represents a 5.86 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.72% of the stock is owned by company insiders.

Silicon Laboratories Price Performance

Silicon Laboratories stock opened at $135.53 on Friday. Silicon Laboratories Inc. has a fifty-two week low of $94.00 and a fifty-two week high of $154.91. The stock has a 50-day simple moving average of $123.32 and a 200-day simple moving average of $115.75.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.07. The firm had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The firm’s revenue was down 18.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.48 EPS. On average, research analysts anticipate that Silicon Laboratories Inc. will post -3.56 earnings per share for the current fiscal year.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.